Rock Springs Capital VC
Investments by market, targeted sectors and preferred funding rounds
Investments by industry
biotech - 57%
healthtech - 43%
Number of investments: 7
Rock Springs Capital invested in Sagimet Biosciences during a round worth $80,000,000 - 2/12/2021
Rock Springs Capital invested in Verve Therapeutics during a round worth $94,000,000 - 1/19/2021
Rock Springs Capital invested in Delfi Diagnostics during a round worth $100,000,000 - 1/13/2021
Rock Springs Capital invested in Affinivax during a round worth $226,000,000 - 1/8/2021
Rock Springs Capital invested in Reneo Pharmaceuticals during a round worth $95,000,000 - 12/11/2020
Rock Springs Capital invested in Genesis Therapeutics during a round worth $52,000,000 - 12/2/2020
Rock Springs Capital invested in Immunocore during a round worth $130,000,000 - 3/18/2020